a public good project by the
Synthesis
Company
of California

© 2026

Axel Grothey | doi.page

0 works0 citations0 h-index

Axel Grothey

West Cancer Center(US)Campbell Clinic(US)

Publications by Year

Research Areas

Colorectal Cancer Treatments and Studies, Gastric Cancer Management and Outcomes, Cancer Treatment and Pharmacology, Genetic factors in colorectal cancer, Cancer Genomics and Diagnostics

Most-Cited Works

→ ESMO consensus guidelines for the management of patients with metastatic colorectal cancer(2016)3,389 cited
→ Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial(2012)2,847 cited
→ Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer(2010)1,600 cited
→ Encorafenib, Binimetinib, and Cetuximab in BRAF V600E–Mutated Colorectal Cancer(2019)1,423 cited
→ Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved Chemotherapy(2009)1,353 cited
→ Duration of Adjuvant Chemotherapy for Stage III Colon Cancer(2018)1,100 cited

→ Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study(2015)

941 cited

→ A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group(2020)716 cited

→ Disease-Free Survival Versus Overall Survival As a Primary End Point for Adjuvant Colon Cancer Studies: Individual Patient Data From 20,898 Patients on 18 Randomized Trials(2005)706 cited